126 related articles for article (PubMed ID: 37545327)
1. The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of Gastric Cancer.
Nie Z; Zeng K; Yan Q; Liu Y; Bian Y; Zhu J; Guo Z; He F; Shi H; Guo Y
Int J Surg Pathol; 2024 May; 32(3):486-495. PubMed ID: 37545327
[TBL] [Abstract][Full Text] [Related]
2. Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis.
Wang J; Shao X; Liu Y; Shi R; Yang B; Xiao J; Liu Y; Qu X; Li Z
Expert Rev Mol Diagn; 2021 Sep; 21(9):963-972. PubMed ID: 34196586
[No Abstract] [Full Text] [Related]
3. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.
Takahashi N; Yamada Y; Taniguchi H; Fukahori M; Sasaki Y; Shoji H; Honma Y; Iwasa S; Takashima A; Kato K; Hamaguchi T; Shimada Y
BMC Res Notes; 2014 Apr; 7():271. PubMed ID: 24774510
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract][Full Text] [Related]
6. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract][Full Text] [Related]
7. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study.
van Grieken NC; Aoyama T; Chambers PA; Bottomley D; Ward LC; Inam I; Buffart TE; Das K; Lim T; Pang B; Zhang SL; Tan IB; Carvalho B; Heideman DA; Miyagi Y; Kameda Y; Arai T; Meijer GA; Tsuburaya A; Tan P; Yoshikawa T; Grabsch HI
Br J Cancer; 2013 Apr; 108(7):1495-501. PubMed ID: 23511561
[TBL] [Abstract][Full Text] [Related]
8. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract][Full Text] [Related]
9. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
10. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
12. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
13. Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.
Abate M; Walch H; Arora K; Vanderbilt CM; Fei T; Drebin H; Shimada S; Maio A; Kemel Y; Stadler ZK; Schmeltz J; Sihag S; Ku GY; Gu P; Tang L; Vardhana S; Berger MF; Brennan MF; Schultz ND; Strong VE
Ann Surg; 2023 Oct; 278(4):506-518. PubMed ID: 37436885
[TBL] [Abstract][Full Text] [Related]
14. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract][Full Text] [Related]
15. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
Lin Y; Wu Z; Guo W; Li J
Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
[TBL] [Abstract][Full Text] [Related]
16. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
Sclafani F; Wilson SH; Cunningham D; Gonzalez De Castro D; Kalaitzaki E; Begum R; Wotherspoon A; Capdevila J; Glimelius B; Roselló S; Thomas J; Tait D; Brown G; Oates J; Chau I
Int J Cancer; 2020 Jan; 146(1):94-102. PubMed ID: 31199501
[TBL] [Abstract][Full Text] [Related]
17. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity.
Queirós P; Pinheiro H; Carvalho J; Oliveira P; Gullo I; Carneiro F; Almeida GM; Oliveira C
Virchows Arch; 2015 Oct; 467(4):383-92. PubMed ID: 26318594
[TBL] [Abstract][Full Text] [Related]
19. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.
Tahara T; Shibata T; Okamoto Y; Yamazaki J; Kawamura T; Horiguchi N; Okubo M; Nakano N; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N
Oncotarget; 2016 Jul; 7(27):42252-60. PubMed ID: 27323394
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
